CLSI M06-A2-2006

VIP免费
那山那人那狗 2025-02-11 36 1.27MB 44 页 16星币
侵权投诉
(Formerly NCCLS)
Providing NCCLS standards and guidelines,
ISO/TC 212 standards, and ISO/TC 76 standards
Clinical and Laboratory Standards Institute
Providing CLSI/NCCLS standards and guidelines, ISO/TC 212 standards, and ISO/TC 76 standards
Clinical and Laboratory Standards Institute (CLSI,
formerly NCCLS) is an international, interdisciplinary,
nonprofit, standards-developing, and educational
organization that promotes the development and use of
voluntary consensus standards and guidelines within the
healthcare community. It is recognized worldwide for the
application of its unique consensus process in the
development of standards and guidelines for patient
testing and related healthcare issues. Our process is
based on the principle that consensus is an effective and
cost-effective way to improve patient testing and
healthcare services.
In addition to developing and promoting the use of
voluntary consensus standards and guidelines, we
provide an open and unbiased forum to address critical
issues affecting the quality of patient testing and health
care.
PUBLICATIONS
A document is published as a standard, guideline, or
committee report.
Standard A document developed through the consensus
process that clearly identifies specific, essential
requirements for materials, methods, or practices for use
in an unmodified form. A standard may, in addition,
contain discretionary elements, which are clearly
identified.
Guideline A document developed through the
consensus process describing criteria for a general
operating practice, procedure, or material for voluntary
use. A guideline may be used as written or modified by
the user to fit specific needs.
Report A document that has not been subjected to
consensus review and is released by the Board of
Directors.
CONSENSUS PROCESS
The CLSI voluntary consensus process is a protocol
establishing formal criteria for:
the authorization of a project
the development and open review of documents
the revision of documents in response to comments
by users
the acceptance of a document as a consensus
standard or guideline.
Most documents are subject to two levels of consensus
“proposed” and “approved.” Depending on the need for
field evaluation or data collection, documents may also be
made available for review at an intermediate consensus
level.
Proposed A consensus document undergoes the first stage
of review by the healthcare community as a proposed
standard or guideline. The document should receive a wide
and thorough technical review, including an overall review
of its scope, approach, and utility, and a line-by-line review
of its technical and editorial content.
Approved An approved standard or guideline has achieved
consensus within the healthcare community. It should be
reviewed to assess the utility of the final document, to
ensure attainment of consensus (i.e., that comments on
earlier versions have been satisfactorily addressed), and to
identify the need for additional consensus documents.
Our standards and guidelines represent a consensus opinion
on good practices and reflect the substantial agreement by
materially affected, competent, and interested parties
obtained by following CLSI’s established consensus
procedures. Provisions in CLSI standards and guidelines
may be more or less stringent than applicable regulations.
Consequently, conformance to this voluntary consensus
document does not relieve the user of responsibility for
compliance with applicable regulations.
COMMENTS
The comments of users are essential to the consensus
process. Anyone may submit a comment, and all comments
are addressed, according to the consensus process, by the
committee that wrote the document. All comments,
including those that result in a change to the document when
published at the next consensus level and those that do not
result in a change, are responded to by the committee in an
appendix to the document. Readers are strongly encouraged
to comment in any form and at any time on any document.
Address comments to Clinical and Laboratory Standards
Institute, 940 West Valley Road, Suite 1400, Wayne, PA
19087, USA.
VOLUNTEER PARTICIPATION
Healthcare professionals in all specialties are urged to
volunteer for participation in CLSI projects. Please contact
us at customerservice@clsi.org or +610.688.0100 for
additional information on committee participation.
M6-A2
ISBN 1-56238-594-1
Volume 26 Number 6 ISSN 0273-3099
Protocols for Evaluating Dehydrated Mueller-Hinton Agar; Approved
Standard—Second Edition
Robert P. Rennie, PhD
Donald R. Callihan, PhD
Arthur L. Barry, PhD
Karen Krisher, PhD, D(ABMM)
Susan D. Munro, MT(ASCP)
Katherine Sei
Roxanne G. Shively, MS
Jana M. Swenson, MMSc
Abstract
Clinical and Laboratory Standards Institute document M6-A2Protocols for Evaluating Dehydrated Mueller-Hinton Agar;
Approved Standard—Second Edition describes three protocols for the evaluation of dehydrated Mueller-Hinton agar in the disk
diffusion procedure for antimicrobial susceptibility testing. The first protocol is for use by manufacturers to evaluate production
lots of Mueller-Hinton agar. The second and third are for selection and stability testing of primary and secondary reference lots of
Mueller-Hinton agar.
Performance of production lots is determined by comparison with the primary standard lot, which is provided to manufacturers
upon request. The secondary standard lot may be used when the supply of the primary standard is threatened or its performance
becomes unsatisfactory. Acceptable lots may be labeled with a statement indicating that the lot was tested according to the
protocol found in this document and meets the acceptance limits of that protocol. These acceptance criteria apply only to disk
diffusion procedures. They do not qualify Mueller-Hinton agar for other methods, such as agar dilution or antibiotic gradient.
Performance of new reference lots is determined by comparison with the current primary standard lot. The original primary
reference standard lot was selected in 1983 and the secondary standard lot in 1984. Replacement reference standards were
selected in 1992, 1996, and again in 2002.
Clinical and Laboratory Standards Institute (CLSI). Protocols for Evaluating Dehydrated Mueller-Hinton Agar; Approved
Standard—Second Edition. CLSI document M6-A2 (ISBN 1-56238-594-1). Clinical and Laboratory Standards Institute, 940
West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2006.
The Clinical and Laboratory Standards Institute consensus process, which is the mechanism for moving a document through
two or more levels of review by the healthcare community, is an ongoing process. Users should expect revised editions of any
given document. Because rapid changes in technology may affect the procedures, methods, and protocols in a standard or
guideline, users should replace outdated editions with the current editions of CLSI/NCCLS documents. Current editions are
listed in the CLSI catalog, which is distributed to member organizations, and to nonmembers on request. If your organization is
not a member and would like to become one, and to request a copy of the catalog, contact us at: Telephone: 610.688.0100; Fax:
610.688.0700; E-Mail: customerservice@clsi.org; Website: www.clsi.org
摘要:

CLSI M06-A2-2006 是美国临床和实验室标准协会(CLSI)发布的一项重要标准,标题为《厌氧菌的抗菌药物敏感性试验方法——第二版》。该标准提供了针对厌氧菌进行抗菌药物敏感性测试的统一操作规范,包括培养基选择、接种物制备、孵育条件、质量控制及结果判读等关键步骤,适用于临床微生物实验室对厌氧菌引起的感染(如腹腔感染、牙源性感染、盆腔感染等)进行准确的药物敏感性评估。遵循此标准有助于提高检测结果的可重复性和临床相关性,指导合理使用抗生素,延缓耐药性发展。该文件适用于实验室技术人员、微生物学

展开>> 收起<<
CLSI M06-A2-2006.pdf

共44页,预览4页

还剩页未读, 继续阅读

声明:本文档系会员上传,若文档所含内容侵犯了您的版权或隐私,请立即通知,我们立即给予侵权申诉删除!
作者:那山那人那狗 分类:国外协会 价格:16星币 属性:44 页 大小:1.27MB 格式:PDF 时间:2025-02-11

开通VIP享超值会员特权

  • 多端同步记录
  • 高速下载文档
  • 免费文档工具
  • 分享文档赚钱
  • 每日登录抽奖
  • 优质衍生服务
/ 44
客服
关注